Effects of Sitagliptin in Individuals With Genetically Decreased DPP4
Effects of Sitagliptin in Individuals With Genetically Decreased DPP4
Active, not recruiting · NCT04323189 · Registry updated 2026-01-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effects of Sitagliptin in Individuals With Genetically Decreased DPP4 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, heart failure, hereditary disease, metabolic disease, type 2 diabetes mellitus | Active, not recruiting | Phase 4 | 2026-01-16 | NCT04323189 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Pennsylvania | 502 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Pennsylvania | Philadelphia | United States | 507 |